Skip to main content
. 2020 Feb;136:162–168. doi: 10.1016/j.urology.2019.09.044

Table 2.

1-, 3-, and 5-year metastasis-free survival rates by Leibovich risk group

Cohorts
Leibovich Risk Group Contemporary UK
n = 384
Historic UK
n = 191
Original Leibovich
n = 1671
1-year MFS rate (%) SE
Low 99 ± 1 98 ± 2 99.5 ± 0.3
Intermediate 98 ± 1 94 ± 3 90.4 ± 1.2
High 77 ± 5 72 ± 7 57.7 ± 2.6
3-year MFS rate (%) SE
Low 97 ± 1 95 ± 3 97.9 ± 0.6
Intermediate 91 ± 2 79 ± 4 79.8 ± 1.7
High 62 ± 6 45 ± 8 37.1 ± 2.7
5-year MFS rate (%) SE
Low 97 ± 1 93 ± 3 97.1 ± 0.7
Intermediate 85 ± 3 76 ± 5 73.8 ± 2.0
High 50 ± 7 37 ± 8 31.2 ± 2.7

SE, standard error.